Orbitrex Peptides
Tirzepatide
Finnrick tested 3 samples of Tirzepatide (GLP-1 and GIP agonist) from Orbitrex Peptides between 23 Nov 2025 and 13 Feb 2026. Test scores average over 7, no score below 6, and at least 2 tests warrant a tentative Finnrick Rating of A (Great).
Finnrick Rating™
Tentative Rating
Orbitrex Peptides
Tirzepatide
Tested 3 Samples
Last test 13 Feb 2026
Take Action
Researcher
Request Full Data Access to the Finnrick database of peptide tests.
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Tirzepatide tests from top-rated vendors:
All Tirzepatide tests from Orbitrex Peptides
Samples are tested in commercial labs
Tests Count
3
Scores
AVGMINMAX
Last
13 Feb 2026
First
23 Nov 2025
| Quantity | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Batch | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 13 Feb 2026 | View | 10mg | 11.4mg | 11.4mg | +0.3% | 99.69% | 2ZG101125 | Yellow Label / Silver Crimp / Yellow Cap | Lab E | Public | |
| 24 Nov 2025 | View | 10mg | ⚠️ Sample does not contain Tirzepatide | 2GTZ1019625 | Yellow Label / Silver Crimp / Yellow Cap | Lab A | Vendor | ||||
| 24 Nov 2025 | View | 10mg | 11.6mg | 11.05mg | -5.0% | 99.58% | 2GTZ1019625 | Yellow Label / Silver Crimp / Yellow Cap | Lab A | Vendor | |
| 23 Nov 2025 | View | 10mg | 11.6mg | 11.18mg | -3.8% | 99.11% | 2GTZ1019625 | Yellow Label / Silver Crimp / Yellow Cap | Lab A | Vendor | |
Corrections
- 9 Mar 2026
- Sample nwwrwhu: original COA reported purity of 92.83%. Upon vendor objection, lab investigated and found the automated integration routine picked up noise as peaks and erroneously integrated it. Manual revision led to updated calculations for purity and quantity. The lab issued an updated COA. This sample's test score changed from 5.9 to 9.0, and the Finnrick Rating for Orbitrex Tirzepatide changed from B to A.